ENERGY: Reducing Breast Cancer Recurrence With Weight Loss

Sponsor
University of California, San Diego (Other)
Overall Status
Completed
CT.gov ID
NCT01112839
Collaborator
Washington University School of Medicine (Other), University of Colorado, Denver (Other), University of Alabama at Birmingham (Other)
692
4
2
57.1
173
3

Study Details

Study Description

Brief Summary

The purpose of the ENERGY trial is to explore whether two different programs that are focused on weight management, through increased exercise and a healthy diet, are feasible, and have an impact on body weight, quality of life and fatigue. Since obesity among breast cancer survivors is associated with recurrence and other co-morbidities, those will be assessed and their impact calculated. Blood samples will be collected to enable analysis of potential mechanisms and differential response across subgroups.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Less Intensive
  • Behavioral: Intensive Group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
692 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Reducing Breast Cancer Recurrence With Weight Loss: A Vanguard Trial
Study Start Date :
May 1, 2010
Actual Primary Completion Date :
Feb 1, 2015
Actual Study Completion Date :
Feb 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Less Intensive Group

Participants in this group would receive print materials on diet and exercise and two individual counseling sessions; one at the beginning of the study and another 6 months later.

Behavioral: Less Intensive
Participants in this group would receive print materials on diet and exercise and two individual counseling sessions; one at the beginning of the study and another 6 months later.

Experimental: Intensive Group

Participants in this group would receive print materials on diet and exercise and attend group sessions that would meet weekly for the first 4 months, then every two weeks for the next 2 months, and then monthly for the next 6 months over the course of one year.

Behavioral: Intensive Group
Participants in this group would receive print materials on diet and exercise and attend group sessions that would meet weekly for the first 4 months, then every two weeks for the next 2 months, and then monthly for the next 6 months over the course of one year.

Outcome Measures

Primary Outcome Measures

  1. Weight loss [2 years]

Secondary Outcome Measures

  1. Improvement in quality of life [2 years]

  2. Improvement in fatigue [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Diagnosis of breast cancer (stages I (≥1 cm), stage II, or stage IIIA, B, C excluding distant metastasis) diagnosed between 6 months and 5 years earlier; after initial therapies are completed, diagnosed between six months and five years earlier

  • BMI between 25 to 45 kg/m2

  • Able to comply with all required study procedures and schedule

Exclusion Criteria:
  • Serious medical condition or psychiatric illness

  • Inability to be moderately physically active

  • Obesity of known endocrine origin (e.g., untreated hypothyroidism, PCOS)

  • Currently enrolled in a weight loss program

  • Current use of weight loss medication or supplements

  • Previous surgical procedures for weight reduction

  • Planning weight loss surgery in the next 2 years.

  • 6+ months use of meds likely to cause weight gain or prevent weight loss

  • Planned surgical procedure that can impact the conduct of the study

  • Currently pregnant/breastfeeding

  • Planning to become pregnant within the next 2 years

  • Have plans to relocate from area within 2 years

  • Family relative or close friend is a trial staff member or a study participant

  • Any condition which in the opinion of the investigator makes the subject unsuitable for inclusion in this study

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35294-3360
2 Moores UCSD Cancer Center La Jolla California United States 92093
3 University of Colorado Denver Aurora Colorado United States 80045
4 Washington University in St. Louis: St. Louis Missouri United States 63110

Sponsors and Collaborators

  • University of California, San Diego
  • Washington University School of Medicine
  • University of Colorado, Denver
  • University of Alabama at Birmingham

Investigators

  • Principal Investigator: Cheryl L. Rock, PhD, RD, University of California, San Diego

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cheryl Rock, Study Principal Investigator, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01112839
Other Study ID Numbers:
  • CA148791-01
First Posted:
Apr 28, 2010
Last Update Posted:
Jun 18, 2015
Last Verified:
Jun 1, 2015
Keywords provided by Cheryl Rock, Study Principal Investigator, University of California, San Diego
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2015